Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 15966752)

1.

Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence.

Elkader A, Sproule B.

Clin Pharmacokinet. 2005;44(7):661-80. Review.

PMID:
15966752
2.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
3.

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.

Middleton LS, Nuzzo PA, Lofwall MR, Moody DE, Walsh SL.

Addiction. 2011 Aug;106(8):1460-73. doi: 10.1111/j.1360-0443.2011.03424.x. Epub 2011 May 3.

4.

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Foster RH, Goa KL.

CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.

PMID:
23338224
5.

Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality.

Harris DS, Mendelson JE, Lin ET, Upton RA, Jones RT.

Clin Pharmacokinet. 2004;43(5):329-40.

PMID:
15080765
6.

Buprenorphine-containing treatments: place in the management of opioid addiction.

Robinson SE.

CNS Drugs. 2006;20(9):697-712. Review.

PMID:
16953647
7.

Spotlight on buprenorphine/naloxone in the treatment of opioid dependence.

Orman JS, Keating GM.

CNS Drugs. 2009 Oct;23(10):899-902. doi: 10.2165/11203740-000000000-00000. Review.

PMID:
19739698
8.

Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.

Stimolo C, Favero VD, Zecchinato G, Buson R, Cusin D, Pellachin P, Simonetto P.

Clin Drug Investig. 2010;30 Suppl 1:27-31. doi: 10.2165/11536030-000000000-00000.

PMID:
20450243
9.

Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine.

Compton P, Ling W, Moody D, Chiang N.

Drug Alcohol Depend. 2006 Mar 15;82(1):25-31. Epub 2005 Sep 6.

PMID:
16144748
10.

Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.

Magnelli F, Biondi L, Calabria R, Fiore A, Peluso E, Vonella D, Rota AG.

Clin Drug Investig. 2010;30 Suppl 1:21-6. doi: 10.2165/11536010-000000000-00000.

PMID:
20450242
11.

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers.

Strain EC, Stoller K, Walsh SL, Bigelow GE.

Psychopharmacology (Berl). 2000 Mar;148(4):374-83.

PMID:
10928310
12.

Buprenorphine for the treatment of opioid dependence.

Boothby LA, Doering PL.

Am J Health Syst Pharm. 2007 Feb 1;64(3):266-72. Review.

PMID:
17244875
13.

Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine.

Kuhlman JJ Jr, Lalani S, Magluilo J Jr, Levine B, Darwin WD.

J Anal Toxicol. 1996 Oct;20(6):369-78.

14.

Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.

Orman JS, Keating GM.

Drugs. 2009;69(5):577-607. doi: 10.2165/00003495-200969050-00006. Review.

PMID:
19368419
15.

Pharmacokinetics of the combination tablet of buprenorphine and naloxone.

Chiang CN, Hawks RL.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S39-47. Review.

PMID:
12738349
16.

Effects of buprenorphine/naloxone in opioid-dependent humans.

Stoller KB, Bigelow GE, Walsh SL, Strain EC.

Psychopharmacology (Berl). 2001 Mar;154(3):230-42.

PMID:
11351930
17.

Buprenorphine: how to use it right.

Johnson RE, Strain EC, Amass L.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S59-77. Review.

PMID:
12738351
18.

High-dose buprenorphine: perioperative precautions and management strategies.

Roberts DM, Meyer-Witting M.

Anaesth Intensive Care. 2005 Feb;33(1):17-25. Review.

PMID:
15957687
19.

Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.

Daitch J, Frey ME, Silver D, Mitnick C, Daitch D, Pergolizzi J Jr.

Pain Physician. 2012 Jul;15(3 Suppl):ES59-66.

20.

Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre.

Montesano F, Zaccone D, Battaglia E, Genco F, Mellace V.

Clin Drug Investig. 2010;30 Suppl 1:13-9. doi: 10.2165/11536040-000000000-00000.

PMID:
20450241
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk